Publication Cover
Neurological Research
A Journal of Progress in Neurosurgery, Neurology and Neurosciences
Volume 36, 2014 - Issue 7
137
Views
12
CrossRef citations to date
0
Altmetric
Original Research Papers

Brain atrophy as a non-response predictor to interferon-beta in relapsing–remitting multiple sclerosis

, , , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (11)

Katariina Hänninen, Matias Viitala, Teemu Paavilainen, Jari O. Karhu, Juha Rinne, Juha Koikkalainen, Jyrki Lötjönen & Merja Soilu-Hänninen. (2020) Thalamic Atrophy Predicts 5-Year Disability Progression in Multiple Sclerosis. Frontiers in Neurology 11.
Crossref
Jaume Sastre-Garriga, Deborah Pareto, Marco Battaglini, Maria A. Rocca, Olga Ciccarelli, Christian Enzinger, Jens Wuerfel, Maria P. Sormani, Frederik Barkhof, Tarek A. Yousry, Nicola De Stefano, Mar Tintoré, Massimo Filippi, Claudio Gasperini, Ludwig Kappos, Jordi Río, Jette Frederiksen, Jackie Palace, Hugo Vrenken, Xavier Montalban & Àlex Rovira. (2020) MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice. Nature Reviews Neurology 16:3, pages 171-182.
Crossref
Beraki Abraha, Arthur R. Chaves, Liam P. Kelly, Elizabeth M. Wallack, Katie P. Wadden, Jason McCarthy & Michelle Ploughman. (2018) A Bout of High Intensity Interval Training Lengthened Nerve Conduction Latency to the Non-exercised Affected Limb in Chronic Stroke. Frontiers in Physiology 9.
Crossref
Jaume Sastre-Garriga, Deborah Pareto & Àlex Rovira. (2017) Brain Atrophy in Multiple Sclerosis. Neuroimaging Clinics of North America 27:2, pages 289-300.
Crossref
Nicola De Stefano, Diego G. Silva & Michael H. Barnett. (2017) Effect of Fingolimod on Brain Volume Loss in Patients with Multiple Sclerosis. CNS Drugs 31:4, pages 289-305.
Crossref
Gavin Giovannoni, Gary Cutter, Maria Pia Sormani, Shibeshih Belachew, Robert Hyde, Harold Koendgen, Volker Knappertz, Davorka Tomic, David Leppert, Robert Herndon, Claudia A.M. Wheeler-Kingshott, Olga Ciccarelli, David Selwood, Elisabetta Verdun di Cantogno, Ali-Frederic Ben-Amor, Paul Matthews, Daniele Carassiti, David Baker & Klaus Schmierer. (2017) Is multiple sclerosis a length-dependent central axonopathy? The case for therapeutic lag and the asynchronous progressive MS hypotheses. Multiple Sclerosis and Related Disorders 12, pages 70-78.
Crossref
Letizia Leocani, Maria A. Rocca & Giancarlo Comi. (2016) MRI and neurophysiological measures to predict course, disability and treatment response in multiple sclerosis. Current Opinion in Neurology 29:3, pages 243-253.
Crossref
Jordi Río & Juan Luís Ruiz-Peña. (2016) Short-term suboptimal response criteria for predicting long-term non-response to first-line disease modifying therapies in multiple sclerosis: A systematic review and meta-analysis. Journal of the Neurological Sciences 361, pages 158-167.
Crossref
Angela Vidal-Jordana, Jaume Sastre-Garriga, Alex Rovira & Xavier Montalban. (2015) Treating relapsing?remitting multiple sclerosis: therapy effects on brain atrophy. Journal of Neurology 262:12, pages 2617-2626.
Crossref
Francisco Carlos Pérez-MirallesJaume Sastre-GarrigaAngela Vidal-JordanaJordi RíoCristina AugerDeborah ParetoMar TintoréAlex RoviraXavier Montalban. (2015) Predictive value of early brain atrophy on response in patients treated with interferon β. Neurology Neuroimmunology & Neuroinflammation 2:4.
Crossref
Douglas L Arnold, David Li, Marika Hohol, Santanu Chakraborty, Jeffrey Chankowsky, Katayoun Alikhani, Pierre Duquette, Virender Bhan, Walter Montanera, Hyman Rabinovitch, William Morrish, Robert Vandorpe, François Guilbert, Anthony Traboulsee & Marcelo Kremenchutzky. (2015) Evolving role of MRI in optimizing the treatment of multiple sclerosis: Canadian Consensus recommendations. Multiple Sclerosis Journal - Experimental, Translational and Clinical 1, pages 205521731558977.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.